5.26BMarket Cap
LossP/E TTM
Institutional Confidence
Currency: USD Updated: 2026-07-02The current institutional shareholding score of Travere Therapeutics Inc is 10.00, ranking 1 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 122.39%, representing a quarter-over-quarter increase of 4.06%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 2.13% of shares outstanding, with 0.71% increase in holdings.
Institutional Shareholding
Shareholder Activity
Janus Henderson Investors
BlackRock Institutional Trust Company, N.A.
Fidelity Management & Research Company LLC
State Street Investment Management (US)
Nomura Investment Management Business Trust
Fidelity Institutional Asset Management
Adage Capital Management, L.P.